Loading…

Loading grant details…

Completed HORIZON European Commission

Enhancing Industrial Cultivation: A Breakthrough Approach Using Methylated Compounds to Expedite Microbial Growth


Funder European Commission
Recipient Organization Weizmann Institute of Science
Country Israel
Start Date Jul 01, 2024
End Date Dec 31, 2025
Duration 548 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 101146837
Grant Description

Accelerating Microbial Cultivation through Lag Phase Shortening using Methylated CompoundsIndustries reliant on microbial cultivation face high production costs, with the cultivation process accounting for 20-40% of the total.

However, conventional strategies often overlook the lag phase, an early growth phase in which bacteria do not grow that significantly elongates the cultivation process and impacts production costs.Recent findings arising from our ERC-funded research, reveal a ground-breaking mechanism for modulating bacterial lag phase duration.

Through the addition of naturally abundant methylated compounds during the lag phase, we demonstrate a strategy to expedite bacterial growth by up to 10 hours.

This approach, previously unexplored due to technical challenges, could revolutionize industrial cultivation, reducing costs and enhancing product yield.Our ERC-funded research uncovered a novel regulatory circuit influencing the bacterial lag phase.

In our research of algal-bacterial routes of metabolic exchange, we discovered that abundant methylated compounds that are produced by algae and plants can significantly expedite the lag phase of various bacteria.

Detailed insights into this mechanism enabled tailored treatments that shorten lag phases by utilizing methylated compounds.

This approach presents a safe, affordable, and unique solution for industry challenges.In this proposal, we outline a comprehensive plan to address current industrial cultivation challenges and exploit our innovative approach.

By leveraging methylated compounds to expedite lag phases, both in bacteria and yeast, we aim to optimize yield, revolutionize microbial cultivation, and potentially transform an industry with an expected value of $130-180 billion by 2030.

All Grantees

Weizmann Institute of Science

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant